<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/newsletter/style.css"/>
<title>UnitedHealth (UNH) Secures Analyst Confidence with Strong Medicare Outlook and Earnings Guidance — Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">UnitedHealth (UNH) Secures Analyst Confidence with Strong Medicare Outlook and Earnings Guidance</h2>
    <div class="badge">2025-09-15T13:07:41+00:00</div>
    <ul>
      <li>Initial results in an 8-K filing indicate that approximately 78% of Medicare Advantage members will be in 4-star or higher plans next year.</li>
<li>On September 10, Bernstein SocGen Group reiterated an Outperform rating on the stock and a $379 price target.</li>
<li>In addition, the research firm has echoed UnitedHealth’s reaffirmation of its 2025 adjusted earnings per share guidance, despite facing significant headwinds this year.</li>
<li>Ken Wolter/Shutterstock.com The positive stance stems from the company signaling stability in its medical benefits business, with solid preliminary 2026 Medicare Advantage Stars results.</li>
<li>Initially, there were concerns of potential guidance cuts under the new CEO.</li>
<li>READ NEXT: 11 Best Wind Power and Solar Stocks to Buy According to Analysts and 10 Best Robinhood Penny Stocks to Invest In.</li>
<li>Disclosure: None.</li>
    </ul>
    <p>
      <a class="btn" href="https://twitter.com/intent/tweet?text=UnitedHealth (UNH) Secures Analyst Confidence with Strong Medicare Outlook and Earnings Guidance\n• Initial results in an 8-K filing indicate that approximately 78% of Medicare Advantage members will be in 4-star or higher plans next year.\n• On September 10, Bernstein SocGen Group reiterated an Outperform rating on the stock and a $379 price target.\n• In addition, the research firm has echoed UnitedHealth’s reaffirmation of its 2025 adjusted earnings per share guidance, despite facing significant headwinds this year.\n• Ken Wolter/Shutterstock.com The positive stance stems from the company signaling stability in its medical benefits business, with solid preliminary 2026 Medicare Advantage Stars results.\n• Initially, there were concerns of potential guidance cuts under the new CEO.\n• READ NEXT: 11 Best Wind Power and Solar Stocks to Buy According to Analysts and 10 Best Robinhood Penny Stocks to Invest In.\n• Disclosure: None." target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a href="https://finance.yahoo.com/news/unitedhealth-unh-secures-analyst-confidence-130741237.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>